Pfizer Prices COVID-19 Treatment Paxlovid at $1,390, But Free Access Remains for Now
-
Pfizer setting price of COVID-19 treatment Paxlovid at $1,390 for a 5-day course.
-
Americans can still access Paxlovid for free, for now. Millions of free courses remain available.
-
New deal reached between Pfizer and U.S. government for continued free access through 2023 for some groups.
-
Paxlovid fully approved by FDA earlier this year for high-risk adults with COVID-19.
-
Merck's COVID-19 treatment Lagevrio also hitting market next week, price not yet confirmed.